Description

Welcome to Season 5 and Episode 77 of the Movement Logic podcast! In this episode, Laurel and Sarah dive into the history of how DEXA scans came to be so ubiquitous, what are the risks around osteoporosis medication, and whether osteoporosis and osteopenia were intended to be diagnoses in the first place. You will learn:

• How was the DEXA score for osteoporosis first decided on
• Was osteopenia supposed to be a diagnosis for treatment
• What role did Merck play in getting more women to take their new drug Fosamax
• What are the risk factors for the side effects of bisphosphonate drugs
• What is the difference between a population risk vs an individual risk
• Why it’s not recommended to get a DEXA scan before you are 65 years old
• The role of iatrogenesis in the medication choices and use for women with osteoporosis

Sign up here for our FREE Live Strength Class (and sample our Bone Density Course) on September 19th at 8:30am PT/11:30am ET with free replay!

Reference links:

Estrogen Matters

North American Menopause Society

Jen Gunter Instagram

How A Bone Disease Grew To Fit The Prescription

Managing Osteoporosis Patients after Long-Term Bisphosphonate Treatment

Long-Term Drug Therapy and Drug Discontinuations and Holidays for Osteoporosis Fracture Prevention: A Systematic Review

Osteoporosis: Innovations in screening and diagnostics

Osteoporosis Treatment